Reviva Pharmaceuticals Newsroom

Maxim Group Maintains Reviva Pharmaceuticals(RVPH.US) With Hold Rating

Futu NewsNov 16 23:31

Reviva Pharmaceuticals Analyst Ratings

BenzingaNov 15 18:11

Reviva Pharm Holdings Price Target Maintained With a $15.00/Share by D. Boral Capital

Dow JonesNov 15 06:25

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

Dow JonesNov 15 06:25

Reviva Pharmaceuticals Analyst Ratings

BenzingaNov 14 07:08

D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $15 Price Target

BenzingaNov 14 07:08

Maxim Group Maintains Reviva Pharmaceuticals(RVPH.US) With Hold Rating

Futu NewsNov 14 04:31

Reviva Pharm Holdings Initiated at Buy by EF Hutton

Dow JonesSep 23 20:46

Maxim Group Maintains Reviva Pharmaceuticals(RVPH.US) With Hold Rating

Futu NewsSep 7 01:31

Maxim Group Reaffirms Their Hold Rating on Reviva Pharmaceuticals Holdings (RVPH)

TipRanksSep 7 00:37

Reviva Pharm Holdings Price Target Maintained With a $17.00/Share by Benchmark

Dow JonesAug 26 22:06

Reviva Pharmaceuticals Analyst Ratings

BenzingaAug 26 21:57

Benchmark Reiterates Speculative Buy on Reviva Pharmaceuticals, Maintains $17 Price Target

BenzingaAug 26 21:56

Maxim Group Downgrades Reviva Pharmaceuticals(RVPH.US) to Hold Rating

Futu NewsAug 16 20:31

Reviva Pharmaceuticals Analyst Ratings

BenzingaAug 16 20:05

HC Wainwright & Co. Reiterates Buy on Reviva Pharmaceuticals, Maintains $14 Price Target

BenzingaJul 11 18:36

Reviva Pharmaceuticals Analyst Ratings

BenzingaJul 11 18:31

HC Wainwright & Co. Reiterates Buy on Reviva Pharmaceuticals, Maintains $14 Price Target

BenzingaJun 20 18:16

Reviva Pharmaceuticals Analyst Ratings

BenzingaJun 20 18:15

Reviva Pharmaceuticals Analyst Ratings

BenzingaJun 11 18:20